Skip to content

Clinical trials

Observational Tuberculosis, Pulmonary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis, Pulmonary Phase: Observational Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20063
20071
20095
20102
20111
20141
20154
20166
20176
20183
20198
20202
20217
202215
20236
20244
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status24
Recruiting8
Not yet recruiting5
Withdrawn2
Terminated2
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University4
Foundation for Innovative New Diagnostics, Switzerland4
Assistance Publique - Hôpitaux de Paris3
Boston Medical Center2
Chinese University of Hong Kong2
Fundació Institut Germans Trias i Pujol2
Huashan Hospital2
National Institute of Allergy and Infectious Diseases (NIAID)2
Peking University Third Hospital2
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis, Pulmonary85
Tuberculosis24
Latent Tuberculosis6
Lung Neoplasms6
Tuberculosis, Multidrug-Resistant5
COVID-194
Pulmonary Disease, Chronic Obstructive4
Tuberculosis, Extrapulmonary4
Disease3
Bronchiectasis2

Trials

Showing 76 to 85 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.